DRKS00024682
Completed
Not Applicable
A retrospective multi-centre analysis investigating the effects of the rate of change in glucose on intermittently scanned continuous glucose monitoring (isCGM) system accuracy in people with type 1 diabetes - ROCI 1
niversität BayreuthInstitut für SportwissenschaftenDivision of Exercise Physiology and Metabolism0 sites311 target enrollmentAugust 30, 2021
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- E10
- Sponsor
- niversität BayreuthInstitut für SportwissenschaftenDivision of Exercise Physiology and Metabolism
- Enrollment
- 311
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participants being clinically diagnosed with type 1 diabetes
- •Using an isCGM system against reference blood glucose measurement
- •Timepoints of measurements noted to assess the rate of change
Exclusion Criteria
- •Any data that is missing in the inclusion criteria
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 4
A study to understand T2D patient characteristics with respect to medicines and clinical featuresCTRI/2022/10/046335ovo Nordisk Pharma Gulf FZE
Completed
Not Applicable
A multi-center retrospective observational study in patients with relapsed and refractory multiple myeloma receiving once-weekly carfilzomib dosing in combination with dexamethasone in a real-world setting in Japan (Weekly-CAR study)Multiple myelomaJPRN-UMIN000043049Ono Pharmaceutical Co., Ltd.150
Completed
Not Applicable
A Multicenter retrospective study to investigate the clinical significance of "suspicious for malignancy" on peritoneal washing cytology in resected pancreatic cancerPatients diagnosed with resectable (R) or borderline resectable (BR) pancreatic cancer according to the General Rules for the Study of Pancreatic Cancer 7th edition written by Japan Pancreas Society, who performed upfront surgery, and diagnosed as suspicious or Class III (difficult to differentiate), Class IV (suspicious of malignancy), or Class V (positive/malignant) by peritoneal washing cytology on laparotomy.JPRN-UMIN000046824niversity of Toyama400
Completed
Not Applicable
A multicenter retrospective observational study evaluating the safety and efficacy of immune checkpoint inhibitors in patients with advanced or recurrent lung cancer after COVID-19 vaccination (NEJ061)advanced or recurrent lung cancerJPRN-UMIN000048096Specified Nonprofit Corporation North East Japan Study Group850
Recruiting
Not Applicable
A multi-center retrospective observational study of effectiveness, safety and treatment status of tirabrutinib in relapsed or refractory pcnsl (ROSETTA)Relapsed or refractory Primary CNS LymphomaPrimary CNS lymphomaD008228JPRN-jRCT1021230006agane Motoo206